<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39456513</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3921</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Antioxidants (Basel, Switzerland)</Title><ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation></Journal><ArticleTitle>Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1260</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox13101260</ELocationID><Abstract><AbstractText>Low-grade endotoxemia by lipopolysaccharide (LPS) has been detected in COVID-19 and could favor thrombosis via eliciting a pro-inflammatory and pro-coagulant state. The aim of this study was to analyze the mechanism accounting for low-grade endotoxemia and its relationship with oxidative stress and clotting activation thrombosis in COVID-19. We measured serum levels of sNOX2-dp, zonulin, LPS, D-dimer, and albumin in 175 patients with COVID-19, classified as having or not acute respiratory distress syndrome (ARDS), and 50 healthy subjects. Baseline levels of sNOX2-dp, LPS, zonulin, D-dimer, albumin, and hs-CRP were significantly higher in COVID-19 compared to controls. In COVID-19 patients with ARDS, sNOX2-dp, LPS, zonulin, D-dimer, and hs-CRP were significantly higher compared to COVID-19 patients without ARDS. Conversely, concentration of albumin was lower in patients with ARDS compared with those without ARDS and inversely associated with LPS. In the COVID-19 cohort, the number of patients with ARDS progressively increased according to sNOX2-dp and LPS quartiles; a significant correlation between LPS and sNOX2-dp and LPS and D-dimer was detected in COVID-19. In a multivariable logistic regression model, LPS/albumin levels and D-dimer predicted thrombotic events. In COVID-19 patients, LPS is significantly associated with a hypercoagulation state and disease severity. In vitro, LPS can increase endothelial oxidative stress and coagulation biomarkers that were reduced by the treatment with albumin. In conclusion, impaired gut barrier permeability, increased NOX2 activation, and low serum albumin may account for low-grade endotoxemia and may be implicated in thrombotic events in COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carnevale</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6216-9595</Identifier><AffiliationInfo><Affiliation>Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Neuromed, 86077 Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nocella</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marocco</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Santa Maria (SM) Goretti Hospital, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccalà</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Santa Maria (SM) Goretti Hospital, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carraro</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7399-5262</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picchio</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1591-5118</Identifier><AffiliationInfo><Affiliation>IRCCS Neuromed, 86077 Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0832-7975</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cangemi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4097-2061</Identifier><AffiliationInfo><Affiliation>Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miele</LastName><ForeName>Maria Claudia</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-2833-2480</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Angelis</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cancelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casciaro</LastName><ForeName>Giovanni Enrico</ForeName><Initials>GE</Initials><Identifier Source="ORCID">0000-0002-9464-5461</Identifier><AffiliationInfo><Affiliation>Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristiano</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0003-7341-9195</Identifier><AffiliationInfo><Affiliation>Helios Hospital West of Munich, 81241 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pignatelli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2265-7455</Identifier><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frati</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2703-3761</Identifier><AffiliationInfo><Affiliation>Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Neuromed, 86077 Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venditti</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2639-0281</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8076-1250</Identifier><AffiliationInfo><Affiliation>Department of General Surgery and Surgical Specialty, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroianni</LastName><ForeName>Claudio Maria</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-1286-467X</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Violi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridola</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8596-2609</Identifier><AffiliationInfo><Affiliation>Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Borgo</LastName><ForeName>Cosmo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Santa Maria (SM) Goretti Hospital, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmerio</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8874-3711</Identifier><AffiliationInfo><Affiliation>Centro Ricerche Cliniche di Verona (CRC), 37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valenzi</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Prevention, ASL Latina, 04011 Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carnevale</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Corso di Laurea di I Livello in Infermieristica, Università Sapienza di Roma-Polo Pontino-Sede di Terracina, 04019 Terracina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvaro</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3771-9644</Identifier><AffiliationInfo><Affiliation>Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtner</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7730-3953</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardinale</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antioxidants (Basel)</MedlineTA><NlmUniqueID>101668981</NlmUniqueID><ISSNLinking>2076-3921</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">NOX2 activation</Keyword><Keyword MajorTopicYN="N">albumin</Keyword><Keyword MajorTopicYN="N">gut permeability</Keyword><Keyword MajorTopicYN="N">low-grade endotoxemia</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39456513</ArticleId><ArticleId IdType="pmc">PMC11505442</ArticleId><ArticleId IdType="doi">10.3390/antiox13101260</ArticleId><ArticleId IdType="pii">antiox13101260</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger J.S. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA. 2020;324:799–801. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraissé M., Logre E., Pajot O., Mentec H., Plantefève G., Contou D. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: A French monocenter retrospective study. Crit. Care. 2020;24:275. doi: 10.1186/s13054-020-03025-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03025-y</ArticleId><ArticleId IdType="pmc">PMC7265664</ArticleId><ArticleId IdType="pubmed">32487122</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Fagot Gandet F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089–1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M., Kaptein F.H.J., van Paassen J., Stals M.A.M., Huisman M.V., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145–147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., Kucher N., Studt J.D., Sacco C., Bertuzzi A., et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. doi: 10.1016/j.thromres.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Berg J. Venous and arterial thromboembolic disease in COVID-19. J. Thromb. Thrombolysis. 2021;52:1007–1009. doi: 10.1007/s11239-021-02524-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02524-1</ArticleId><ArticleId IdType="pmc">PMC8276541</ArticleId><ArticleId IdType="pubmed">34255267</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam S.S., Key N.S., Greenberg C.S. D-dimer antigen: Current concepts and future prospects. Blood. 2009;113:2878–2887. doi: 10.1182/blood-2008-06-165845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-06-165845</ArticleId><ArticleId IdType="pubmed">19008457</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E.D., Schell J.C., Rodgers G.M. The D-dimer assay. Am. J. Hematol. 2019;94:833–839. doi: 10.1002/ajh.25482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25482</ArticleId><ArticleId IdType="pubmed">30945756</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitz J.I., Fredenburgh J.C., Eikelboom J.W. A Test in Context: D-Dimer. J. Am. Coll. Cardiol. 2017;70:2411–2420. doi: 10.1016/j.jacc.2017.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.09.024</ArticleId><ArticleId IdType="pubmed">29096812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gungor B., Atici A., Baycan O.F., Alici G., Ozturk F., Tugrul S., Asoglu R., Cevik E., Sahin I., Barman H.A. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am. J. Emerg. Med. 2021;39:173–179. doi: 10.1016/j.ajem.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.09.018</ArticleId><ArticleId IdType="pmc">PMC7489326</ArticleId><ArticleId IdType="pubmed">33069541</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Thachil J., Iba T., Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438–e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844–847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingaropoli M.A., Nijhawan P., Carraro A., Pasculli P., Zuccala P., Perri V., Marocco R., Kertusha B., Siccardi G., Del Borgo C., et al. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front. Immunol. 2021;12:627548. doi: 10.3389/fimmu.2021.627548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.627548</ArticleId><ArticleId IdType="pmc">PMC7993197</ArticleId><ArticleId IdType="pubmed">33777012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cangemi R., Calvieri C., Bucci T., Carnevale R., Casciaro M., Rossi E., Calabrese C.M., Taliani G., Grieco S., Falcone M., et al. Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? Antioxid. Redox Signal. 2014;20:2949–2954. doi: 10.1089/ars.2013.5766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5766</ArticleId><ArticleId IdType="pmc">PMC4038979</ArticleId><ArticleId IdType="pubmed">24328853</ArticleId></ArticleIdList></Reference><Reference><Citation>Cangemi R., Della Valle P., Calvieri C., Taliani G., Ferroni P., Falcone M., Carnevale R., Bartimoccia S., D’Angelo A., Violi F. Low-grade endotoxemia and clotting activation in the early phase of pneumonia. Respirology. 2016;21:1465–1471. doi: 10.1111/resp.12854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.12854</ArticleId><ArticleId IdType="pubmed">27403788</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes E., Gibbins J.M., Holbrook L.M., Palomo I. NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis. Trends Cardiovasc. Med. 2018;28:429–434. doi: 10.1016/j.tcm.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2018.03.001</ArticleId><ArticleId IdType="pubmed">29661712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer P.M., Mc Intyre S.A., Thomas D.C. Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation. Front. Immunol. 2021;12:733918. doi: 10.3389/fimmu.2021.733918.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.733918</ArticleId><ArticleId IdType="pmc">PMC8440999</ArticleId><ArticleId IdType="pubmed">34539670</ArticleId></ArticleIdList></Reference><Reference><Citation>To E.E., Vlahos R., Luong R., Halls M.L., Reading P.C., King P.T., Chan C., Drummond G.R., Sobey C.G., Broughton B.R.S., et al. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nat. Commun. 2017;8:69. doi: 10.1038/s41467-017-00057-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00057-x</ArticleId><ArticleId IdType="pmc">PMC5507984</ArticleId><ArticleId IdType="pubmed">28701733</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva A., Cammisotto V., Cangemi R., Ferro D., Miele M.C., De Angelis M., Cancelli F., Pignatelli P., Venditti M., Pugliese F., et al. Low-Grade Endotoxemia and Thrombosis in COVID-19. Clin. Transl. Gastroenterol. 2021;12:e00348. doi: 10.14309/ctg.0000000000000348.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000348</ArticleId><ArticleId IdType="pmc">PMC8183715</ArticleId><ArticleId IdType="pubmed">34092777</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevale R., Sciarretta S., Valenti V., di Nonno F., Calvieri C., Nocella C., Frati G., Forte M., d’Amati G., Pignataro M.G., et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: Implication for myocardial infarction. Eur. Heart J. 2020;41:3156–3165. doi: 10.1093/eurheartj/ehz893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz893</ArticleId><ArticleId IdType="pubmed">31898723</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L.B., Dweep H., Yin X., Wang H., Damra M., Goldman A.R., Gorman N., Palmer C.S., Tang H.Y., Shaikh M.W., et al. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front. Immunol. 2021;12:686240. doi: 10.3389/fimmu.2021.686240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Gilboa T., Ogata A.F., Senussi Y., Lazarovits R., Boribong B.P., Bartsch Y.C., Loiselle M., Rivas M.N., Porritt R.A., et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Investig. 2021;131:e149633. doi: 10.1172/JCI149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrugia A., Mori F. Therapeutic Solutions of Human Albumin—The Possible Effect of Process-Induced Molecular Alterations on Clinical Efficacy and Safety. J. Pharm. Sci. 2022;111:1292–1308. doi: 10.1016/j.xphs.2022.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2022.03.005</ArticleId><ArticleId IdType="pubmed">35276228</ArticleId></ArticleIdList></Reference><Reference><Citation>Paar M., Rossmann C., Nusshold C., Wagner T., Schlagenhauf A., Leschnik B., Oettl K., Koestenberger M., Cvirn G., Hallström S. Anticoagulant action of low, physiologic, and high albumin levels in whole blood. PLoS ONE. 2017;12:e0182997. doi: 10.1371/journal.pone.0182997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182997</ArticleId><ArticleId IdType="pmc">PMC5553770</ArticleId><ArticleId IdType="pubmed">28800610</ArticleId></ArticleIdList></Reference><Reference><Citation>De Simone G., di Masi A., Ascenzi P. Serum Albumin: A Multifaced Enzyme. Int. J. Mol. Sci. 2021;22:86. doi: 10.3390/ijms221810086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221810086</ArticleId><ArticleId IdType="pmc">PMC8466385</ArticleId><ArticleId IdType="pubmed">34576249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.A., Tsao Y.C., Chen A., Lo G.H., Lin C.K., Yu H.C., Cheng L.C., Hsu P.I., Tsai W.L. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand. J. Gastroenterol. 2009;44:619–625. doi: 10.1080/00365520902719273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365520902719273</ArticleId><ArticleId IdType="pubmed">19191184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Zhang Y., Zhao X., Tao M., Yan W., Fu Y. Hypoalbuminemia—An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis. Infect. Drug Resist. 2021;14:3699–3710. doi: 10.2147/IDR.S327090.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S327090</ArticleId><ArticleId IdType="pmc">PMC8437137</ArticleId><ArticleId IdType="pubmed">34526790</ArticleId></ArticleIdList></Reference><Reference><Citation>Soetedjo N.N.M., Iryaningrum M.R., Damara F.A., Permadhi I., Sutanto L.B., Hartono H., Rasyid H. Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis. Clin. Nutr. ESPEN. 2021;45:120–126. doi: 10.1016/j.clnesp.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8288213</ArticleId><ArticleId IdType="pubmed">34620307</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuschak G.M., Lechner A.J. Acute lung injury and the acute respiratory distress syndrome: Pathophysiology and treatment. Mo. Med. 2010;107:252–258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188356</ArticleId><ArticleId IdType="pubmed">20806836</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.P., Huisman M.V., Humbert M., Jennings C.S., Jimenez D., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Eur. Heart J. 2020;41:543–603. doi: 10.1183/13993003.01647-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01647-2019</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H., Caforio A.L.P., Crea F., Goudevenos J.A., Halvorsen S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur. Heart J. 2018;39:119–177. doi: 10.1093/eurheartj/ehx393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx393</ArticleId><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan W.N., Ovbiagele B., Black H.R., Bravata D.M., Chimowitz M.I., Ezekowitz M.D., Fang M.C., Fisher M., Furie K.L., Heck D.V., et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–2236. doi: 10.1161/STR.0000000000000024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000024</ArticleId><ArticleId IdType="pubmed">24788967</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaca M.P., Gutierrez J.A., Creager M.A., Scirica B.M., Olin J., Murphy S.A., Braunwald E., Morrow D.A. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2 degrees P-TIMI 50) Circulation. 2016;133:997–1005. doi: 10.1161/CIRCULATIONAHA.115.019355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019355</ArticleId><ArticleId IdType="pubmed">26826179</ArticleId></ArticleIdList></Reference><Reference><Citation>Osband A.J., Deitch E.A., Hauser C.J., Lu Q., Zaets S., Berezina T., Machiedo G.W., Rajwani K.K., Xu D.Z. Albumin protects against gut-induced lung injury in vitro and in vivo. Ann. Surg. 2004;240:331–339. doi: 10.1097/01.sla.0000133359.12284.6b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133359.12284.6b</ArticleId><ArticleId IdType="pmc">PMC1356411</ArticleId><ArticleId IdType="pubmed">15273559</ArticleId></ArticleIdList></Reference><Reference><Citation>Park B.S., Lee J.O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp. Mol. Med. 2013;45:e66. doi: 10.1038/emm.2013.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2013.97</ArticleId><ArticleId IdType="pmc">PMC3880462</ArticleId><ArticleId IdType="pubmed">24310172</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F., Cammisotto V., Bartimoccia S., Pignatelli P., Carnevale R., Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat. Rev. Cardiol. 2023;20:24–37. doi: 10.1038/s41569-022-00737-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-022-00737-2</ArticleId><ArticleId IdType="pmc">PMC9284488</ArticleId><ArticleId IdType="pubmed">35840742</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–1833.e3. doi: 10.1053/j.gastro.2020.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsounis E.P., Triantos C., Konstantakis C., Marangos M., Assimakopoulos S.F. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J. Virol. 2023;12:68–90. doi: 10.5501/wjv.v12.i2.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v12.i2.68</ArticleId><ArticleId IdType="pmc">PMC10075050</ArticleId><ArticleId IdType="pubmed">37033148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M.S., Jadhav A.B., Hassan A., Meng Q.H. Acute phase reactants as novel predictors of cardiovascular disease. ISRN Inflamm. 2012;2012:953461. doi: 10.5402/2012/953461.</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/953461</ArticleId><ArticleId IdType="pmc">PMC3767354</ArticleId><ArticleId IdType="pubmed">24049653</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Lowell C.A. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 1997;185:1661–1670. doi: 10.1084/jem.185.9.1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.185.9.1661</ArticleId><ArticleId IdType="pmc">PMC2196288</ArticleId><ArticleId IdType="pubmed">9151903</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevale R., Raparelli V., Nocella C., Bartimoccia S., Novo M., Severino A., De Falco E., Cammisotto V., Pasquale C., Crescioli C., et al. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J. Hepatol. 2017;67:950–956. doi: 10.1016/j.jhep.2017.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2017.07.002</ArticleId><ArticleId IdType="pubmed">28716745</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Ma X., Huang G. Understanding thrombosis: The critical role of oxidative stress. Hematology. 2024;29:2301633. doi: 10.1080/16078454.2023.2301633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16078454.2023.2301633</ArticleId><ArticleId IdType="pubmed">38186217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen K.A., Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb. Res. 1980;17:13–18. doi: 10.1016/0049-3848(80)90289-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(80)90289-3</ArticleId><ArticleId IdType="pubmed">6990546</ArticleId></ArticleIdList></Reference><Reference><Citation>Maclouf J., Kindahl H., Granstrom E., Samuelsson B. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin. Eur. J. Biochem. 1980;109:561–566. doi: 10.1111/j.1432-1033.1980.tb04828.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1980.tb04828.x</ArticleId><ArticleId IdType="pubmed">7408901</ArticleId></ArticleIdList></Reference><Reference><Citation>Jøorgensen K.A., Stoffersen E. Heparin like activity of albumin. Thromb. Res. 1979;16:569–574. doi: 10.1016/0049-3848(79)90105-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(79)90105-1</ArticleId><ArticleId IdType="pubmed">516011</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F., Ceccarelli G., Loffredo L., Alessandri F., Cipollone F., D’Ardes D., D’Ettorre G., Pignatelli P., Venditti M., Mastroianni C.M., et al. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb. Haemost. 2021;121:102–105. doi: 10.1055/s-0040-1721486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1721486</ArticleId><ArticleId IdType="pmc">PMC7869060</ArticleId><ArticleId IdType="pubmed">33368057</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman H.J., Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021;20:689–709. doi: 10.1038/s41573-021-00233-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00233-1</ArticleId><ArticleId IdType="pmc">PMC8243062</ArticleId><ArticleId IdType="pubmed">34194012</ArticleId></ArticleIdList></Reference><Reference><Citation>Pussinen P.J., Kopra E., Pietiäinen M., Lehto M., Zaric S., Paju S., Salminen A. Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia. Periodontology 2000. 2022;89:19–40. doi: 10.1111/prd.12433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12433</ArticleId><ArticleId IdType="pmc">PMC9314839</ArticleId><ArticleId IdType="pubmed">35244966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>